Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1999 Jul;80(10):1565–1568. doi: 10.1038/sj.bjc.6690561

BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas

S Gill 1, J Broni 1, S Jefferies 2, P Osin 3, G Kovacs 4, N J Maitland 5, R Eeles 2, S M Edwards 2, M J S Dyer 6, T G Willis 6; the M. P. T. Collaborators7; the St George's Hospital Collaborators7, C S Cooper 1
PMCID: PMC2363098  PMID: 10408398

Abstract

We have used single-strand conformation polymorphism (SSCP) analysis to screen for mutations in the BCL10 gene in 81 primary prostate carcinomas, 20 squamous cell cancers of the head and neck, 15 small-cell lung cancer cell lines, 24 renal carcinoma cell lines and 13 sarcoma cell lines. We failed to find evidence of somatically acquired mutations of the BCL10 gene suggesting that BCL10 does not play a major role in the development of these malignancies. © 1999 Cancer Research Campaign

Keywords: BCL10, mutation, prostate cancer, sarcomas, lung cancer, renal carcinoma, head and neck squamous cell cancers

Full Text

The Full Text of this article is available as a PDF (114.2 KB).

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES